Application of Apamarga Ksharodak and Intralesional Cidofovir in the management of Charmakeela(Warts)

Evaluation of comparative efficacy of Intralesional Apamarga Ksharodak versus Intralesional Cidofovir in the management of Charmakeela(Warts)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/01/048654

Enrollment

Registered

2023-01-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing with written informed consent as per Helsinki declaration. 2. Age group of 17 to 70 years. 3. Patients with clinical features of warts of painless , small ,rough and hard growth similar to skin . 4. Patients irrespective of gender, occupation and economic status.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled and insulin dependent Diabetes Mellitus, Uncontrolled Hypertension , Tuberculosis, Carcinoma , Endocrine Disorders and Kidney or hepatic disorder. 2. Sites of warts – sensitive places like : genitals, eye lids, lips, etc . 3. History of anticoagulants and haemophilla. 4. Pregnant and lactating females. 5. Substantial abnormalities in hematological

Design outcomes

Primary

Measure	Time frame
First assesment will be of pain, Size of charmakeela.Timepoint: 1 week	—

Secondary

Measure	Time frame
Secondary Assesment will be of Shed off day and Scar .Timepoint: 2 weeks	—

Countries

India

Contacts

Public ContactDr Devyani Dasar

Mahatma Gandhi Ayurved College Hospital and Research Centre

devyanidasar06@gmail.com9503630392

Outcome results